Ocular Staining Outperforms Schirmer Test in Sjögren Study
New research shows ocular staining scores provide higher diagnostic accuracy for identifying Sjögren dry eye disease.
Updated on Oct. 23, 2026 in Arthritis
Live Poll
Should eye care professionals adopt more precise diagnostic tests for early detection of Sjögren disease?
Researchers have determined that the Schirmer test displays significantly lower diagnostic sensitivity for Sjögren dry eye disease compared to ocular staining scores. The findings suggest a shift in how medical professionals evaluate ocular health in patients suspected of having the condition.
Why it matters
Current medical guidelines weigh Schirmer tests and ocular staining scores equally when diagnosing Sjögren disease, potentially masking accurate results. Updating diagnostic priorities could ensure patients receive more precise evaluations and faster access to emerging treatments.
The study of 3514 SICCA cohort participants found the ocular staining score reached 91.4% sensitivity and 83.9% specificity for Sjögren disease. By contrast, the Schirmer test demonstrated only 47.5% sensitivity during the comparative analysis.
The players
ACR/EULAR
This body maintains the international classification criteria used by clinicians to diagnose Sjögren disease.
SICCA
The Sjögren’s International Collaborative Clinical Alliance provides extensive data for research into the disease.
The details
Using latent class analysis, researchers evaluated four diagnostic tests to determine their accuracy in identifying Sjögren dry eye disease. While the Schirmer test struggled with sensitivity, other methods like fluorescein staining performed with 82.6% sensitivity and 88.8% specificity.
Timeline
The ACR/EULAR criteria for Sjögren disease were established in 2016.
Research findings were presented on October 23, 2026, at the 17th International Symposium in Paris.
Disease-modifying drugs for the condition could become available in 2027.
The Big Picture
The study challenges the established framework of the 2016 ACR/EULAR criteria for Sjögren disease. By identifying significant performance gaps between standard tests, the findings signal a likely departure from current clinical diagnostic protocols.
Patients undergoing evaluation for Sjögren dry eye may experience more accurate diagnosis if physicians prioritize ocular staining over Schirmer tests. This shift aims to reduce misdiagnosis and prepare individuals for upcoming targeted therapies.
The takeaway
Patients should discuss which diagnostic tests are being used during their ocular evaluations to ensure the most sensitive methods are applied. Advancements in protein analysis may soon allow for even more personalized risk assessments.
What happens next
New disease-modifying drugs for Sjögren disease are expected to become available for patient use in 2027.
Further reading
For broader context on current clinical research, visit the Arthritis section.
Source note: This article includes information reported by Medscape.
Live Poll
Should eye care professionals adopt more precise diagnostic tests for early detection of Sjögren disease?
